RSV is a highly infectious virus that is the most common cause of respiratory infections in children. A free vaccine could soon be available to help prevent it.
GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.
Findings showed a noninferior immune response for both vaccines when Shingrix and Arexvy were coadministered compared with separate administration (primary endpoint). Both anti-gE antibody ...
British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
The news comes as coronavirus cases rise in California and across the country. Along with the new COVID vaccines, ...
Starting in September, the UK’s new RSV vaccine program will offer protection across all age groups — find out what this ...
COVID-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already ...
The Taliban have suspended polio vaccination campaigns in Afghanistan, the U.N. said Monday. Afghanistan is one of two countries in which the spread of the ...
All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...